The Alluvi Retatrutide 40mg pen is a pre-filled research delivery format for retatrutide — the triple GLP-1/GIP/glucagon receptor agonist. This guide explains what the pen format offers compared to vial-based reconstitution, how it fits into research protocols, and where UK-based scientists access Alluvi-branded research stock through EvolvelabsUK.